DiaMedica Therapeutics Inc (NASDAQ:DMAC)

7.97
BATS BZX Real-Time Price
As of 11:17am ET
 -0.10 / -1.24%
Today’s Change
1.87
Today|||52-Week Range
10.88
-21.40%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for DiaMedica Therapeutics Inc have a median target of 15.50, with a high estimate of 28.00 and a low estimate of 14.00. The median estimate represents a +94.48% increase from the last price of 7.97.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in DiaMedica Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.17
Sales
$0.00
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.84%
 
 
 
 
 
 
Growthannually 19.10%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.